Your browser doesn't support javascript.
loading
Multi attribute method implementation using a High Resolution Mass Spectrometry platform: From sample preparation to batch analysis.
Carvalho, Sofia B; Gomes, Ricardo A; Pfenninger, Anja; Fischer, Martina; Strotbek, Michaela; Isidro, Inês A; Tugçu, Nihal; Gomes-Alves, Patrícia.
Afiliação
  • Carvalho SB; iBET, Instituto de Biologia Experimental e Tecnologica, Oeiras, Portugal.
  • Gomes RA; ITQB-NOVA, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
  • Pfenninger A; iBET, Instituto de Biologia Experimental e Tecnologica, Oeiras, Portugal.
  • Fischer M; ITQB-NOVA, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
  • Strotbek M; Sanofi R&D, Biologics Development, Industriepark Höchst, Frankfurt am Main, Germany.
  • Isidro IA; Sanofi R&D, Biologics Development, Industriepark Höchst, Frankfurt am Main, Germany.
  • Tugçu N; Sanofi R&D, Biologics Development, Industriepark Höchst, Frankfurt am Main, Germany.
  • Gomes-Alves P; iBET, Instituto de Biologia Experimental e Tecnologica, Oeiras, Portugal.
PLoS One ; 17(1): e0262711, 2022.
Article em En | MEDLINE | ID: mdl-35085302
Quality control of biopharmaceuticals such as monoclonal antibodies (mAbs) has been evolving and becoming more challenging as the requirements of the regulatory agencies increase due to the demanding complexity of products under evaluation. Mass Spectrometry (MS)-based methods such as the multi-attribute method (MAM) are being explored to achieve a deeper understanding of the attributes critical for the safety, efficacy, and quality of these products. MAM uses high mass accuracy/high-resolution MS data that enables the direct and simultaneous monitoring of relevant product quality attributes (PQAs, in particular, chemical modifications) in a single workflow, replacing several orthogonal methods, reducing time and costs associated with these assays. Here we describe a MAM implementation process using a QTOF high resolution platform. Method implementation was accomplished using NIST (National Institute for Standards and Technology) mAb reference material and an in-process mAb sample. PQAs as glycosylation profiles, methionine oxidation, tryptophan dioxidation, asparagine deamidation, pyro-Glu at N-terminal and glycation were monitored. Focusing on applications that require batch analysis and high-throughput, sample preparation and LC-MS parameters troubleshooting are discussed. This MAM workflow was successfully explored as reference analytical tool for comprehensive characterization of a downstream processing (DSP) polishing platform and for a comparability study following technology transfer between different laboratories.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espectrometria de Massas / Produtos Biológicos Tipo de estudo: Prognostic_studies Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Portugal

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espectrometria de Massas / Produtos Biológicos Tipo de estudo: Prognostic_studies Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Portugal
...